DGAP-Adhoc: Biotest AG: Biotest increases revenues

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Feb 13, 2015 at 5:15 AM

DGAP-Adhoc: Biotest AG: Biotest increases revenues significantly by 16.2%

Biotest AG / Key word(s): Preliminary Results 13.02.2015 10:59 Dissemination of an Ad hoc announcement according to Â§ 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Ad-hoc RELEASE Announcement according to Â§ 15 Sec. 1 Securities Trading Act (WpHG) Biotest increases revenues significantly by 16.2% Dreieich, 13. February 2015. According to preliminary and unaudited figures, the Biotest Group increased revenues to EUR 582.0 million. This represents an increase of 16.2% compared to the previous year (EUR 500.8 million). Biotest successfully gained market shares - particularly in the Middle and Far East. On account of advanced research and development cost, additional expenses relating to the planed production capacity expansion at the headquarters in Dreieich, Germany, as well as overall lower margin business, especially in crisis regions, Group's earnings before interest and tax (EBIT) came in at EUR 53.4 million at the previous year EBIT level (EUR 53.8 million). Biotest will publish final results for the Financial Year 2014 and the annual report on March 24th, 2015. The Annual General Meeting of Biotest AG will take place on May 7th, 2015 in Frankfurt am Main, Germany. Biotest Aktiengesellschaft Board of Management Biotest AG Landsteinerstr. 5 D-63303 Dreieich www.biotest.de Disclaimer This document contains forward-looking statements on overall economic development as well as on the business, earnings, financial and assets position of Biotest AG and its subsidiaries. These statements are based on current plans, estimates, forecasts and expectations of the company and are thus subject to risks and elements of uncertainty that could result in significant deviation of actual developments from expected developments. The forward-looking statements are only valid at the time of publication. Biotest does not intend to update the forward-looking statements and assumes no obligation to do so. About Biotest Biotest is a provider of plasma proteins and biotherapeutic drugs. With a value added chain that extends from pre-clinical and clinical development to worldwide sales, Biotest has specialised primarily in the areas of clinical immunology, haematology and intensive medicine. Biotest develops and markets immunoglobulins, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and haematopoietic systems. In addition Biotest develops monoclonal antibodies in the indications of rheumatoid arthritis and cancer of plasma cells, which are produced by recombinant technologies. Biotest has more than 2.100 employees worldwide. The preference shares of Biotest AG are listed in the SDAX on the Frankfurt stock exchange. Securities' ID No., ISIN ordinary shares: 522720, DE0005227201 Securities' ID No., ISIN preference shares: 522723, DE0005227235 Listing: Prime Standard Open market: Berlin-Bremen, DÃ¼sseldorf, Frankfurt, Hamburg, Hannover, MÃ¼nchen, Stuttgart 13.02.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Biotest AG LandsteinerstraÃe 5 63303 Dreieich Germany Phone: 0 61 03 - 8 01-0 Fax: 0 61 03 - 8 01-150 E-mail: investor_relations@biotest.de Internet: http://www.biotest.de ISIN: DE0005227235, DE0005227201 WKN: 522723, 522720 Indices: SDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

XCMG Climbs Fortune China 500: Strengthens Global Edge

XCMG's Ascent on the Fortune China 500 When it comes to scaling new heights, XCMG Machinery is clearly in the driver's seat, roaring up the Fortune China 500 to claim the 202nd spot, leaping ten ranks from last year. While others may coast, XCMG's trajectory is anything but idle, retaining its crown among Chinese construction machinery titans. The recent summit in Chengdu...

Seeking Balance in Home Care Staffing: BVNA's Stand

Time to Set the Record Straight: Why Home Care Deserves Our Attention Out here in Pittsfield, Massachusetts, there's a showdown brewing between the Berkshire Visiting Nurse Association (BVNA) and its dedicated crew—those frontline warriors delivering care where it's most personal, right at home. Picture this: a petition lands squarely on the management's desk at 4 p.m....

New Ambulatory Surgery Center in Alabama Breaks Ground

Breaking New Ground: USOP and SOS Lead the Charge You can almost hear the construction noise starting up in Montgomery, Alabama, where U.S. Orthopaedic Partners (USOP) and Southern Orthopaedic Surgeons (SOS) have just launched an ambitious new project. They're not just cutting ceremonial ribbons; they're slicing into the future of orthopedic care in Central Alabama. The...

TELUS Digital Named a Key Player in T&S Services 2026

Climbing the Ranks It’s not often you see a tech outfit surge ahead and pull off the kind of leaps TELUS Digital just managed. According to the Everest Group’s 2026 Trust and Safety Services PEAK Matrix® Assessment, TELUS Digital emerged as a Leader for the first time, riding high on advanced AI initiatives. Not just a pat on the back—that’s a big deal...

DFW Cash Offers: Better Way Home Solutions' Edge

Cash Offers in the Real Estate Maze In Dallas–Fort Worth, selling a home isn't your TV show montage. It's a challenging minefield of tenant headaches, quick moves, and foreclosure pressures. You know, sometimes it's not even about staging photos and waiting for that glamorous open house. Nope, some folks just need cash—and fast. Why Cash is King in DFW Let's cut the...

Common Thread Advisors: Transforming Change in Business

Navigating the Storm of Change: A New Player in Town You know, just when you think you've got the business world figured out, something sharp comes along. Today, it’s Common Thread Advisors, making its grand entrance to help organizations steer through the dense fog of change. This isn’t your everyday, run-of-the-mill consultancy. No sir, they’re out here with a...

Blue Moon Metals Gears Up for Springer Mine Revamp

Getting Set for a Big Move Blue Moon Metals Inc. isn't sitting around with its thumbs in its pockets. The company has made some strides with their Springer Tungsten Mine project in Imlay, Nevada. Let's break down what these folks are up to. Refurbished Up for the Fast Track The rock mover here is the refurbishment of the Springer processing plant. You don't just snap your...

Meta's Bold Move: $25B Offering and New Stocks

Meta's New Financial Adventure Well, when Meta talks money, you better believe the market listens. This time, they’ve got a whopping pair of offerings on the table—one for depositary shares and another for their Class A common stock. Meta, under the ticker NASDAQ:META, isn't holding back, with a $25 billion upsized offering that's bound to rattle some cages. A Deeper...

Capacity LLC: Finalist in 2026 BeautyMatter Awards

A Nod to Logistics and Beauty When beauty meets logistics, you end up with something like Capacity LLC making headlines in the 2026 BeautyMatter Awards. Now, I ain't one to usually get excited about anything involving freight and boxes, but this isn't just any nod in the 'Best Logistics Solution' category; it speaks volumes about where the beauty business is heading. Why...

Commvault's Q2 Fiscal 2027 Shines Bright Amid Complexity

Finding Stability in a Shifting Tech Landscape It doesn’t take a crystal ball to see that Commvault is navigating the whirlwind of tech innovation with some serious flair. Their latest quarterly earnings report for Q2 fiscal 2027 is a testament to the rising demand they're experiencing in a world where data protection and resilience are more than just buzzwords. Diving...